Lehman Department of Pathology and Laboratory Medicine Brown Cancer Center Department of Biochemistry and Molecular Genetics University of Louisville 505 South Hancock Street Louisville, KY 40202 USA [email protected] Submitted: 03 April 2022 Accepted: 12 August 2022 Copyedited by: Jeffrey Nirschl Published: 26 August 2022 Keywords: Malignant melanotic nerve sheath tumor, MMNST, Psammomatous melanotic schwannoma, Nerve sheath tumor, Pigmented epithelioid melanocytoma, PRKAR1A, KMT2C, GNAQ Abstract Malignant melanotic nerve sheath tumor (MMNST) is a rare and potentially aggressive lesion defined in the 2021 WHO Classification of Tumors of the Central Nervous System
Preclinical and mechanistic studies demonstrate that luteolin inhibits mast cell activation and mediator release, providing biologic rationale for its adjunctive use in mast cellrelated conditions
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
Very dry skin, however, might benefit more from formulations with lipid-based vehicles for better absorption
A 40%+ discount warrants investigation
